CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 884546
SAN FRANCISCO, CA
Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$857,745,736
+$14,849,304 QoQ
Shares Held
1,920,871
+3.3% QoQ
Ownership
0.757%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.99286781881761.ToString("F0")%
Shared 0.ToString("F0")%
None 0.007132181182390697.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,184,692,793 across 287 Biotechnology names. VRTX ranks #1 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $857,745,736 | 1,920,871 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $842,896,432 | 1,859,221 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $716,674,176 | 1,829,931 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $789,617,850 | 1,773,625 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $836,450,734 | 1,725,281 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $670,031,992 | 1,663,849 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $756,381,462 | 1,626,347 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $752,757,757 | 1,605,986 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $650,679,382 | 1,556,612 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $614,080,829 | 1,509,206 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $510,283,412 | 1,467,428 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $510,221,640 | 1,449,864 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $454,689,174 | 1,443,137 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $408,920,565 | 1,416,028 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $401,864,147 | 1,387,940 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $384,387,484 | 1,364,092 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $346,428,802 | 1,327,466 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $277,066,684 | 1,261,688 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $225,283,659 | 1,241,985 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $245,270,595 | 1,216,439 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $259,248,668 | 1,206,425 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $297,924,768 | 1,260,577 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $352,296,892 | 1,294,638 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $358,794,129 | 1,235,900 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $277,334,056 | 1,165,514 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||